Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/7/2025

Tapering Protocol for Conjugated Estrogens

General Tapering Principles

  • The American College of Physicians recommends gradual tapering of conjugated estrogens to minimize potential withdrawal symptoms and hormonal fluctuations, with a reduction of 10% of the previous dose every 2-4 weeks 1
  • Monitor for withdrawal symptoms after each dose reduction before proceeding to the next step, adjusting the taper schedule as needed, according to the clinical guidelines 1
  • For patients who have been on conjugated estrogens for years, much slower tapers are required compared to those on short-term therapy, with 10% reductions per month 1

Managing Withdrawal Symptoms

  • Common withdrawal symptoms include hot flashes, mood changes, sleep disturbances, and vaginal dryness, and if severe symptoms occur, return to the previous well-tolerated dose and slow the taper further 1
  • For significant vasomotor symptoms, consider non-hormonal alternatives such as low-dose antidepressants, lifestyle modifications, and adequate hydration and regular exercise, as recommended by the Mayo Clinic 2

Common Pitfalls to Avoid

  • Avoid abrupt discontinuation, which can lead to sudden onset of menopausal symptoms, and do not extend the time between dose reductions indefinitely; maintain momentum in the tapering process while respecting patient tolerance 1

REFERENCES

1

Citalopram Tapering Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025